Impact of parathyroidectomy on allograft outcomes in kidney transplantation

Transpl Int. 2012 Dec;25(12):1248-56. doi: 10.1111/j.1432-2277.2012.01564.x. Epub 2012 Sep 29.

Abstract

We performed retrospective, multi-center study of the impacts of parathyroidectomy (PTX) after or before kidney transplantation on allograft outcomes. A total of 63 patients who underwent PTX after kidney transplantation were identified. Deterioration in eGFR by more than 25% at 1 month after PTX occurred in 20% of the patients. The baseline eGFR was significantly lower in impairment group than nonimpairment group [adjusted odds ratio (OR) 0.87, 95% confidence interval (CI) 0.77-0.99, P = 0.033]. Low iPTH concentration after PTX was also a significant risk factor for the renal impairment (OR 0.96, CI 0.94-0.99, P = 0.009). A total of 37 patients who underwent PTX before transplantation were identified. Thirty-six percent of the patients had persistent hyperparathyroidism by 1 year after transplantation. A high iPTH level before PTX was a significant risk factor for persistent post-transplant hyperparathyroidism (adjusted OR 1.002, CI 1.000-1.005, P = 0.039). Finally, eGFR values during the first 5 years after transplantation were significantly lower in the patients who underwent PTX at less than 1 year after transplantation, than the pretransplant PTX patients (P = 0.032). As PTX after kidney transplantation has a risk of deterioration of allograft function, pretransplant PTX should be considered for patients with severe hyperparathyroidism, who could undergo post-transplant PTX.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Hyperparathyroidism / etiology
  • Hyperparathyroidism / physiopathology
  • Hyperparathyroidism / surgery
  • Kidney Transplantation* / physiology
  • Male
  • Parathyroid Hormone
  • Parathyroidectomy*
  • Retrospective Studies
  • Time Factors
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Parathyroid Hormone